A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
about
Innate Immune Memory: The Latest Frontier of AdjuvanticityTuberculosis vaccines: barriers and prospects on the quest for a transformative toolAccelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.The next 10 years for tuberculosis vaccines: do we have the right plans in place?A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines.Novel vaccination approaches to prevent tuberculosis in childrenBacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.TB Vaccines: The (Human) Challenge Ahead.Gamma-irradiated bacille Calmette-Guérin vaccination does not modulate the innate immune response during experimental human endotoxemia in adult malesOptimization of a Human Bacille Calmette-Guérin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.The current state of tuberculosis vaccinesTB or not TB: that is no longer the question.A review of clinical models for the evaluation of human TB vaccines.Innate immune memory: Implications for host responses to damage-associated molecular patterns.Human biomarkers: can they help us to develop a new tuberculosis vaccine?Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model.Design of tuberculosis vaccine trials under financial constraints.Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity.What Have We Learnt about BCG Vaccination in the Last 20 Years?Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjectsDevelopment of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.Recent developments in tuberculosis vaccines
P2860
Q26783968-8419DFFE-D595-4BFE-9668-985CC90D0281Q28390218-5D87CF91-D425-4BF6-AD6E-AF4F45163633Q30403003-10A81E58-DDA3-4FD4-8E74-8744D1EAEB3FQ33659150-41A1694D-35AD-4698-9603-E8309AB4D2C9Q33697290-992D2B15-7058-46D4-ACC8-BC1AE248C7FAQ33801426-9CAEFBF5-3ED3-44B8-B4BA-2F2139D2CC87Q34300368-DDD9D6F7-D1C5-4261-A27D-C7AFFE78030EQ34676075-CA28DA58-EBBC-4EC7-85FD-692F50C31E29Q35343353-6BE0E9AC-FDA7-4EC6-A323-92EBBC2CB349Q36562820-6DDAFA50-67DE-43A6-AD58-F87BB0342762Q36926207-2FB09D49-1C79-4960-BA57-75CF05EBF54BQ37530123-B81DF4A5-233E-46A1-917D-94C5FA06285EQ37671936-C52079C0-5D28-41E9-8EC1-9A86A1A3A58FQ38041566-9D67840A-9AF0-40A1-821D-2B155C881B46Q38116351-5089E50E-CCAC-4D2A-950E-1CF390C5922AQ38166990-FF3A731C-2FB3-4B85-9FE7-486A6D6367ACQ38711772-39F07E4F-78F6-4A49-A436-31EAF2E78D76Q38771560-D4D75AEA-7544-4926-8817-51E10988ABBBQ38839838-0D0537F8-85A2-4FC4-9073-A44328828C1CQ39323110-308D8853-3E54-464C-8F65-54648AC1E54FQ39497862-B1046113-F079-4092-A5E9-A337676BAE86Q40714734-714CBE46-8A59-4699-833F-F754F0332F4AQ40828543-FD8A3FA7-3EBA-4AD2-8B3A-3E3C4532A3D8Q41684091-54168089-0A11-443C-B25E-7B0B3FF1ADA4Q41996690-DA3A2E0A-D329-4985-923D-9C8429D5B1CAQ42088558-669F825F-0A61-49DA-8A9C-E495392A6EDBQ51742073-A2555493-EDB0-4920-84FC-0E4DB61264CCQ58834925-B75B7DAA-6706-48FC-9443-B6B3ABA64F01
P2860
A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@en
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@nl
type
label
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@en
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@nl
prefLabel
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@en
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@nl
P2093
P2860
P356
P1476
A human challenge model for My ...... bovis bacille Calmette-Guerin.
@en
P2093
Angela M Minassian
Ian D Poulton
Iman Satti
Joel Meyer
P2860
P304
P356
10.1093/INFDIS/JIS012
P407
P577
2012-04-01T00:00:00Z